SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment

Disclosure: S. Korpaisarn: None. J. Arunakul: None. K. Chaisuksombat: None. T. Rattananukrom: None. Background: A feminizing hormone therapy (FHT) for transgender women (TW) who have not undergone gonadectomy consists of estrogens and antiandrogens. Cyproterone acetate (CPA) is the most common antia...

Descripción completa

Detalles Bibliográficos
Autores principales: Korpaisarn, Sira, Arunakul, Jiraporn, Chaisuksombat, Kewalin, Rattananukrom, Teerapong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Transgender Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554800/
http://dx.doi.org/10.1210/jendso/bvad114.2068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554800/
http://dx.doi.org/10.1210/jendso/bvad114.2068

Ejemplares similares